• Realizing The Benefits Of Bringing The Trial To The Patient

    Clinical Research News | During the worst days of the COVID-19 pandemic, drug sponsors, clinical sites, and patients alike discovered the value of in-home services in allowing research studies to proceed while minimizing patients’ potential exposure to the virus from on-site visits. Such services were a lifeline to the research industry. Today, in-home services are being baked into trial protocols not out of dire necessity, but rather out of an appreciation for their value in supporting patient-centric trials with decentralised components.

    May 26, 2023
  • News and Products from Trialbee, Flatiron, Sanofi, Phesi, Personalis, More

    Clinical Research News | Trialbee enhances recruitment strategy; Flatiron and Sanofi set out to redesign the clinical trial experience for sponsors, sites, and patients; and Phesi has published the first edition of its Digital Patient Profile (DPP) catalog. Plus: partnerships for Culmination Bio, Cofactor Genomics, Personalis, Ono Pharmaceuticals, National Cancer Center, and more.

    May 24, 2023
  • As CVS Slowly Exits Clinical Trial Business, Walgreens Continues Ramp-Up

    Clinical Research News | Last week, CVS Health announced its intension to phase out of the clinical trial business with a full exit expected by the end of 2024. In a conversation with Clinical Research News, Walgreens Chief Clinical Trials Officer Ramita Tandon applauds her colleagues at CVS for being the first mover. She is also reassuring Walgreens stakeholders that “we are not going away.”

    May 23, 2023
  • New Antimicrobial Susceptibility Test Suggests Generic Z-Pak Can Cure Superbugs

    Clinical Research News | A new antimicrobial susceptibility testing (AST) method developed by scientists at the University of California, Santa Barbara, resolves the longstanding conflict between what the gold-standard assay says will work and actual patient outcomes when it comes to selecting antibiotics. The alternative AST protocol reveals that antibiotics already widely available on the market can cure superbugs.

    May 18, 2023